Atovaquone
In the US, Atovaquone (atovaquone systemic) is a member of the drug class miscellaneous antibiotics and is used to treat Babesiosis, Malaria, Pneumocystis Pneumonia, Pneumocystis Pneumonia Prophylaxis and Toxoplasmosis.
US matches:
- Atovaquone
- Atovaquone/proguanil
- Atovaquone and proguanil
- Atovaquone y proguanil
- Atovaquone and chloroguanide
- Atovaquone and Proguanil Hydrochloride
- Atovaquone/Proguanil Hydrochloride
UK matches:
- ATOVAQUONE/PROGUANIL HYDROCHLORIDE 250MG/ 100MG FILM-COATED TABLETS (Leaflet)
- ATOVAQUONE/PROGUANIL HYDROCHLORIDE 250MG/100MG FILM-COATED TABLETS (Leaflet)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
P01AX06
CAS registry number (Chemical Abstracts Service)
0095233-18-4
Chemical Formula
C22-H19-Cl-O3
Molecular Weight
366
Therapeutic Category
Antiprotozoal
Chemical Name
2-[trans-4-(p-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone (WHO)
Foreign Names
- Atovaquonum (Latin)
- Atovaquon (German)
- Atovaquone (French)
- Atovacuona (Spanish)
Generic Names
- Atovaquone (OS: USAN, BAN, DCF)
- 566C (IS: Burroughs Wellcome)
- 566C80 (IS: Burroughs Wellcome)
- BW 566C-80 (IS)
- Compound 566 (IS: Burroughs Wellcome)
- DRG-0084 (IS)
- UNII-Y883P1Z2LT (IS)
- Atovaquone (PH: USP 34)
Brand Names
- Atovaquone and Proguanil hydrochloride Glenmark (Atovaquone and Proguanil)
Glenmark, United States - Malanil (Atovaquone and Proguanil)
GlaxoSmithKline, South Africa - Malarone Bambini (Atovaquone and Proguanil (pediatric))
GlaxoSmithKline, Italy - Malarone (Atovaquone and Proguanil)
GlaxoSmithKline, Austria; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Chile; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Estonia; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Iceland; GlaxoSmithKline, Italy; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Latvia; GlaxoSmithKline, Malta; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Poland; GlaxoSmithKline, Portugal; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovenia; GlaxoSmithKline, United States - Malarone Junior (Atovaquone and Proguanil (pediatric))
GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Germany; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, Sweden - Malarone Paediatric (Atovaquone and Proguanil (pediatric))
GlaxoSmithKline, Estonia; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Israel - Malarone Pediatric (Atovaquone and Proguanil (pediatric))
GlaxoSmithKline, Canada - Mepron
GlaxoSmithKline, Canada; GlaxoSmithKline, Poland; GlaxoSmithKline, United States - Wellvone
GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Germany; GlaxoSmithKline, Spain; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Italy; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Sweden; GlaxoSmithKline, South Africa
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.


